|
Volumn 45, Issue 10, 2014, Pages 3089-3091
|
Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke
|
Author keywords
death associated protein kinases; stroke
|
Indexed keywords
DEATH ASSOCIATED PROTEIN KINASE;
DEATH ASSOCIATED PROTEIN KINASE 1;
PROTEIN P53;
TRANSACTIVATOR PROTEIN;
UNCLASSIFIED DRUG;
DAPK1 PROTEIN, MOUSE;
HYBRID PROTEIN;
NEUROPROTECTIVE AGENT;
PEPTIDE;
ADULT;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BRAIN CELL;
CEREBROVASCULAR ACCIDENT;
EXPERIMENTAL MODEL;
IN VIVO STUDY;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
THERAPY EFFECT;
TUMOR SUPPRESSOR GENE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DISEASE MODEL;
METABOLISM;
PROTEIN DOMAIN;
SYNTHESIS;
ANIMALS;
DEATH-ASSOCIATED PROTEIN KINASES;
DISEASE MODELS, ANIMAL;
MICE;
NEUROPROTECTIVE AGENTS;
PEPTIDES;
PROTEIN INTERACTION DOMAINS AND MOTIFS;
RECOMBINANT FUSION PROTEINS;
STROKE;
TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 84919744877
PISSN: 00392499
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/STROKEAHA.114.006348 Document Type: Article |
Times cited : (31)
|
References (7)
|